Are You Keeping Tabs on What Management Is Doing With Your Money?

Find out what you can do to keep yourself from staying up at night wondering about what companies like Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) are doing with your hard-earned money.

| More on:

The idea behind making an investment in the equity of a publicly traded company is that you’re essentially handing over your hard-earned capital to the company’s managers, who you are expecting to earn you a fair return on your investment.

But how sure are you that’s what’s happening with the investments you currently own?

Understanding the shareholder-manager agency problem

The shareholder-manager agency problem is a problem that is about as old as capitalism itself.

The problem arises because the shareholders — that would be you as an investor, or the owner of a company — are the one providing the capital, or money, to pay the bills, hire staff, and invest in capital expenses like plants and equipment.

Yet it’s actually not you, but rather the employees, or management, of the company who are actually the ones responsible for making the hiring, firing and investment decisions on a day-to-day basis.

That means it’s up to the owners — and not the senior managers — of the company to ensure that management is making responsible decisions with the profits of the firm.

Let’s take a closer look at the options available to management as to what they are able to do with a firm’s capital and how those decisions can impact shareholder wealth.

Mergers and acquisitions

This is potentially the avenue most fraught with disastrous outcomes. That’s because sometimes managers of a company find themselves incentive to pursue merger and acquisition (M&A) opportunities to meet certain financial targets.

But the problem arises when those managers place undue emphasis on short-term financial incentives, like year-end bonuses, at the expense of more positive long-term shareholder outcomes.

That type of scenario can lead to disastrous investment outcomes. Look no further than the fate that befell Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) as but one recent example of an M&A strategy gone wrong.

Retiring debt obligations

Management can use a firm’s profits to retire outstanding debt obligations; sometimes it makes sense, and in other cases, not so much.

If, on the one hand, your firm (for example, the aforementioned Valeant Pharmaceuticals) has racked up an unsustainable balance of debt, paying down those financial obligations can be the responsible thing to do.

On the other hand, it may raise questions as to how management got themselves in that position in the first place.

In most cases, firms will target what is referred to as an optimal capital structure — or the optimal mix of debt in relation to assets and equity. Allocating capital in this manner can be an indication that management is, in fact, creating shareholder wealth by adding to or subtracting from its liabilities.

Returning profits to shareholders through dividends and buybacks

Paying a healthy and growing dividend has to be the most tried and true — and probably most “fail-safe” — approach to dealing with shareholders’ money in a responsible and sustainable manner.

Returning firm profits via either dividends or buybacks ensures that shareholders have a say on where the money will be directed — either through reinvestment in the firm or otherwise.

Bottom line

The best thing that investors can do for themselves to help mitigate the risk of the shareholder-manager agency problem is to only invest in companies with demonstrable track records of creating shareholder wealth.

Following that simple rule of thumb will help keep you from staying awake at night wondering what those strangers are doing with your money.

Stay Foolish.

Fool contributor Jason Phillips has no position in any of the stocks mentioned. Tom Gardner owns shares of Valeant Pharmaceuticals. The Motley Fool owns shares of Valeant Pharmaceuticals.

More on Dividend Stocks

investor schemes to buy stocks before market notices them
Dividend Stocks

New to Investing? Here Are 5 Canadian Stocks to Hold Forever

With their well-established businesses, resilient cash flows, and attractive long-term growth prospects, these five Canadian stocks are well positioned to…

Read more »

boy in bowtie and glasses gives positive thumbs up
Dividend Stocks

Best Blue-Chip Dividend Stocks in Canada

Even for the best of blue-chip dividend stocks, investors should still seek to buy at a margin of safety.

Read more »

Income and growth financial chart
Dividend Stocks

Here Are 4 Top Canadian Stocks That Just Raised Their Dividends

Are you looking for Canadian stocks that regularly increase their dividends? These four stocks just raised their dividends by a…

Read more »

hand stacking money coins
Dividend Stocks

The Top 3 Dividend Stocks in Canada for a $10,000 Portfolio

Given their reliable business models, consistent payout, and healthy growth prospects, these three dividend stocks offer attractive buying opportunities.

Read more »

Canadian Dollars bills
Dividend Stocks

A 4.9% Dividend Stock Paying Monthly Cash

If you want a nice 4.9% monthly dividend from a stable, low-risk stock, this REIT could deliver steady long-term returns.

Read more »

cookies stack up for growing profit
Dividend Stocks

1 Undervalued Canadian Dividend Stock I’d Buy Now and Hold for Years

Magna’s stock is near a 52-week high, but rising profits, cash flow, and buybacks could mean it’s still undervalued.

Read more »

diversification is an important part of building a stable portfolio
Dividend Stocks

I Split $15,000 Across 3 TSX Stocks for $770 in Passive Income

Here's how a $15,000 portfolio focused on solid TSX stocks could earn as much as $770/year of steady, predictable passive…

Read more »

A woman shops in a grocery store while pushing a stroller with a child
Dividend Stocks

TFSA Investors: 2 Canadian Stocks to Buy and Hold for Life

Two boring, durable Canadian businesses could compound well inside a TFSA, but both are priced like high-quality companies.

Read more »